Published ahead of print on February 2, 2006, doi:10.1164/rccm.200509-1452OC
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 977-984, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200509-1452OC
Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease
Craig P. Hersh,
Dawn L. DeMeo,
Ross Lazarus,
Juan C. Celedón,
Benjamin A. Raby,
Joshua O. Benditt,
Gerard Criner,
Barry Make,
Fernando J. Martinez,
Paul D. Scanlon,
Frank C. Sciurba,
James P. Utz,
John J. Reilly and
Edwin K. Silverman
Channing Laboratory, and Pulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Washington, Seattle, Washington; Temple University, Philadelphia, Pennsylvania; National Jewish Medical and Research Center, Denver, Colorado; University of Michigan, Ann Arbor, Michigan; Mayo Clinic, Rochester, Minnesota; and University of Pittsburgh, Pittsburgh, Pennsylvania
Correspondence and requests for reprints should be addressed to Craig P. Hersh, M.D., M.P.H., Channing Laboratory, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115. E-mail: craig.hersh{at}channing.harvard.edu
Rationale: Patients with severe chronic obstructive pulmonary disease (COPD) may have varying levels of disability despite similar levels of lung function. This variation may reflect different COPD subtypes, which may have different genetic predispositions.
Objectives: To identify genetic associations for COPD-related phenotypes, including measures of exercise capacity, pulmonary function, and respiratory symptoms.
Methods: In 304 subjects from the National Emphysema Treatment Trial, we genotyped 80 markers in 22 positional and/or biologically plausible candidate genes. Regression models were used to test for association, using a test–replication approach to guard against false-positive results. For significant associations, effect estimates were recalculated using the entire cohort. Positive associations with dyspnea were confirmed in families from the Boston Early-Onset COPD Study.
Results: The test–replication approach identified four genes—microsomal epoxide hydrolase (EPHX1), latent transforming growth factor- binding protein-4 (LTBP4), surfactant protein B (SFTPB), and transforming growth factor-1 (TGFB1)—that were associated with COPD-related phenotypes. In all subjects, single-nucleotide polymorphisms (SNPs) in EPHX1 (p  0.03) and in LTBP4 (p 0.03) were associated with maximal output on cardiopulmonary exercise testing. Markers in LTBP4 (p 0.05) and SFTPB (p = 0.005) were associated with 6-min walk test distance. SNPs in EPHX1 were associated with carbon monoxide diffusing capacity (p 0.04). Three SNPs in TGFB1 were associated with dyspnea (p 0.002), one of which replicated in the family study (p = 0.02).
Conclusions: Polymorphisms in several genes seem to be associated with COPD-related traits other than FEV1. These associations may identify genes in pathways important for COPD pathogenesis.
Key Words: dyspnea • emphysema • exercise tolerance • genetic association • pulmonary function tests
This article has been cited by other articles:
|
|
|
|
 
J-Q He, M G Foreman, K Shumansky, X Zhang, L Akhabir, D D Sin, S F P Man, D L DeMeo, A A Litonjua, E K Silverman, et al.
Associations of IL6 polymorphisms with lung function decline and COPD
Thorax,
August 1, 2009;
64(8):
698 - 704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Cho, D. M. Ciulla, B. J. Klanderman, C. P. Hersh, A. A. Litonjua, D. Sparrow, B. A. Raby, and E. K. Silverman
Analysis of Exonic Elastin Variants in Severe, Early-Onset Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol.,
June 1, 2009;
40(6):
751 - 755.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S J Marciniak and D A Lomas
What can naturally occurring mutations tell us about the pathogenesis of COPD?
Thorax,
April 1, 2009;
64(4):
359 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Castaldi, C. P. Hersh, J. J. Reilly, and E. K. Silverman
Genetic Associations With Hypoxemia and Pulmonary Arterial Pressure in COPD
Chest,
March 1, 2009;
135(3):
737 - 744.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A R Bentley, P Emrani, and P A Cassano
Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review
Thorax,
November 1, 2008;
63(11):
956 - 961.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Foreman, D. L. DeMeo, C. P. Hersh, V. J. Carey, V. S. Fan, J. J. Reilly, S. D. Shapiro, and E. K. Silverman
Polymorphic variation in surfactant protein B is associated with COPD exacerbations
Eur. Respir. J.,
October 1, 2008;
32(4):
938 - 944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Ammous, N. R. Hackett, M. W. Butler, T. Raman, I. Dolgalev, T. P. O'Connor, B.-G. Harvey, and R. G. Crystal
Variability in Small Airway Epithelial Gene Expression Among Normal Smokers
Chest,
June 1, 2008;
133(6):
1344 - 1353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Hersh, D. L. DeMeo, and E. K. Silverman
National Emphysema Treatment Trial State of the Art: Genetics of Emphysema
Proceedings of the ATS,
May 1, 2008;
5(4):
486 - 493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. DeMeo, E. J. Campbell, A. F. Barker, M. L. Brantly, E. Eden, N. G. McElvaney, S. I. Rennard, R. A. Sandhaus, J. M. Stocks, J. K. Stoller, et al.
IL10 Polymorphisms Are Associated with Airflow Obstruction in Severe {alpha}1-Antitrypsin Deficiency
Am. J. Respir. Cell Mol. Biol.,
January 1, 2008;
38(1):
114 - 120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. K. Silverman
Exacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression?
Proceedings of the ATS,
December 1, 2007;
4(8):
586 - 590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shi, S. Bellusci, and D. Warburton
Lung Development and Adult Lung Diseases
Chest,
August 1, 2007;
132(2):
651 - 656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. DeMeo, C. P. Hersh, E. A. Hoffman, A. A. Litonjua, R. Lazarus, D. Sparrow, J. O. Benditt, G. Criner, B. Make, F. J. Martinez, et al.
Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial
Am. J. Respir. Crit. Care Med.,
July 1, 2007;
176(1):
42 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1222 - 1232.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shifren, A. G. Durmowicz, R. H. Knutsen, E. Hirano, and R. P. Mecham
Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysema
Am J Physiol Lung Cell Mol Physiol,
March 1, 2007;
292(3):
L778 - L787.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Morris and D. Sheppard
Pulmonary Emphysema: When More is Less.
Physiology,
December 1, 2006;
21(6):
396 - 403.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Warburton, J. Gauldie, S. Bellusci, and W. Shi
Lung Development and Susceptibility to Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2006;
3(8):
668 - 672.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shifren and R. P. Mecham
The stumbling block in lung repair of emphysema: elastic fiber assembly.
Proceedings of the ATS,
July 1, 2006;
3(5):
428 - 433.
[Abstract]
[Full Text]
[PDF]
|
|
|
Copyright © 2006 American Thoracic Society
|
|
|
